SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
119 For my own education, could you please describe what advantages NTII has over CTheSlowLane-4/16/1997
118 Price to Mohr...... "net? what's a net?" Net/net what's a PrJohn Metcalf-4/16/1997
117 Price must've learned how to use a modem. Mohr to Price...... "hey,scaram(o)uche-4/15/1997
116 There are some new Board members for NTII. If they are able to do for the compaDr. John M. de Castro-4/15/1997
115 Thanks again Rick. >> Henry? Post something to the LGND thread? ;-) I kPeter Silsbee-4/10/1997
114 Allergan has the rights, from Children's (Lipton et al.), for opthalmic indscaram(o)uche-4/9/1997
113 Can anyone clarify the limits/extent of NTII's rights to Memantine? I have Peter Silsbee-4/9/1997
112 I haven't read the article, but I'm certain that he's referring to Dr. John M. de Castro-4/9/1997
111 Thanks, Richard. Drug discovery is so much more coherent when someone is williNANCY JEWETT-4/5/1997
110 Nope, haven't read it. Maybe John has. I guarantee, however, that he is mscaram(o)uche-4/4/1997
109 // With the very recent development of clinically-tolerated NMDA antagonisHoward Frederick-4/4/1997
108 Nancy......... macrophages (glia), TNF, IL-1b, and IL-6. Sounds like inflammscaram(o)uche-4/3/1997
107 Memantine blocks the final common path of a number of inflamatory reactions thaDr. John M. de Castro-3/31/1997
106 Thanks for your informed response. By the way, I've heard that any anologyNANCY JEWETT-3/30/1997
105 Mohr Davidow Ventures II is the one I had in mind. They disposed of over 600,00Dr. John M. de Castro-3/29/1997
104 By the venture capitalists deciding to pull out, do you mean Van Kaspar? What NANCY JEWETT-3/25/1997
103 Memantine Aids Dementia results will not be available until probably Q1 19Dr. John M. de Castro-3/25/1997
102 I can't believe this myself, but I too bought more shares. I never buy at Sam Quentin-3/22/1997
101 None of the events of the last few months have adversely impacted my belief thaRobert Cohen-3/22/1997
100 Sam, on the financing issue I spoke to Shawn Johnson earlier this week and he sJohn Wright-3/20/1997
99 Nothing is happening that is visible to the outsider. Except for the MemantineJohn Metcalf-3/20/1997
98 Hi John: Any idea on what's happening to this stock. The whole bio industSam Quentin-3/20/1997
97 What is going on with this stock? Any ideas?Kenneth E. De Paul-3/18/1997
96 John, thanks for the update. This is my second consecutive post where I've John Wright-3/9/1997
95 John (W), the Van Kasper-lead follow-on was thirteen months ago, and is no longJohn Metcalf-3/9/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News